Health News
- New Cancer Treatment For Late Stage Lung Cancer That Was Developed At Uk Is Approved For Clinical Trials
Researchers at the University of Kentucky have pioneered a new medical device for the treatment of late stage lung cancer, which has now been approved for clinical trials by the U.S. Food and Drug Administration at UK, auniversity news release says....
- Kentucky Gets A $7 Million Grant To Improve Survival Rates For Lung Cancer, In Which It Leads The Nation
The University of Kentucky, the University of Louisville and the Lung Cancer Alliance have joined in a unique project called Kentucky LEADS (Lung Cancer, Education, Awareness, Detection, Survivorship) Collaborative to assess new approaches for identifying...
- Uk Creates Nation's First Cancer-reporting System That Uses Electronic Health Records
Kentucky has the highest incidence of cancer in the United States, but it is about to be a national leader in delivering information about cancer cases to researchers. With the help of an almost $1 million Centers for Disease Control grant, the University...
- Markey Cancer Center At Uk Says Its Patients Have Higher Survival Rates Than Those Treated Elsewhere In Ky. And The Nation
"Patients at the University of Kentucky's Markey Cancer Center who have certain types of cancer have higher rates of survival than patients with the same cancers treated elsewhere in the state or even the nation according to new data released today,"...
- Breaking Down The Myths Of Clinical Trials
by Judy Bosley RN, BSN, Oncology Research Nurse Manager The Alvin and Lois Lapidus Cancer Institute Hearing the diagnosis of cancer can be a life changing event. The diagnosis can create many different feelings, anger, disbelief, sadness and shock. Once...
Health News
UK researchers work to improve identification of lung cancer patients eligible for participation in clinical trials for new treatments
At the University of Kentucky, researchers are developing better strategies to identify lung cancer patients who could participate in clinical trials for new treatments. Lung cancer causes more deaths than any other kind of cancer worldwide, and Kentucky's rates of lung cancer and mortality are the highest in the nation.
Unfortunately, fewer than 1 percent of lung cancer patients participate in clinical trials in part because identifying and recruiting eligible participants is difficult and time-consuming, Mallory Powell writes for UK. The disease is often diagnosed so late that there is little time for clinical trials.
"The combination of the burden of lung cancer in Kentucky and the urgency of identifying patients who are eligible for clinical trials motivated Dr. Eric Durben and his team to devise a more efficient method for screening patient eligibility," Powell writes. Durben is director of the Cancer Research Informatics Shared Resource Facility at UK's Markey Cancer Center and an assistant professor in the division of biomedical informatics in the College of Public Health.
Durbin and his team are using unique electronic data sources managed by UK's Center for Clinical and Translational Science, the Institute for Pharmaceutical Outcomes and Policy, the Markey Cancer Center and the Kentucky Cancer Registry to create system system to identify patients who for clinical trials. The two-year project is in its seventh month.
"Clinical trial recruitment is critically important to the Markey Cancer Center if we're going to get lifesaving therapeutics to our patients," said Dr. Susanne Arnold, associate professor in medical oncology and radiation medicine at Markey. "It's also how we make progress in cancer treatment."
While the project is geared toward lung cancer, its results could address other cancers. "What's really exciting about Dr. Durbin's study is that it has the potential to greatly improve clinical research not only in the lung cancer but in other cancers and disease conditions as well," said Dr. Nathan Vanderford, assistant director for research at Markey. (Read more)
Unfortunately, fewer than 1 percent of lung cancer patients participate in clinical trials in part because identifying and recruiting eligible participants is difficult and time-consuming, Mallory Powell writes for UK. The disease is often diagnosed so late that there is little time for clinical trials.
"The combination of the burden of lung cancer in Kentucky and the urgency of identifying patients who are eligible for clinical trials motivated Dr. Eric Durben and his team to devise a more efficient method for screening patient eligibility," Powell writes. Durben is director of the Cancer Research Informatics Shared Resource Facility at UK's Markey Cancer Center and an assistant professor in the division of biomedical informatics in the College of Public Health.
Durbin and his team are using unique electronic data sources managed by UK's Center for Clinical and Translational Science, the Institute for Pharmaceutical Outcomes and Policy, the Markey Cancer Center and the Kentucky Cancer Registry to create system system to identify patients who for clinical trials. The two-year project is in its seventh month.
"Clinical trial recruitment is critically important to the Markey Cancer Center if we're going to get lifesaving therapeutics to our patients," said Dr. Susanne Arnold, associate professor in medical oncology and radiation medicine at Markey. "It's also how we make progress in cancer treatment."
While the project is geared toward lung cancer, its results could address other cancers. "What's really exciting about Dr. Durbin's study is that it has the potential to greatly improve clinical research not only in the lung cancer but in other cancers and disease conditions as well," said Dr. Nathan Vanderford, assistant director for research at Markey. (Read more)
- New Cancer Treatment For Late Stage Lung Cancer That Was Developed At Uk Is Approved For Clinical Trials
Researchers at the University of Kentucky have pioneered a new medical device for the treatment of late stage lung cancer, which has now been approved for clinical trials by the U.S. Food and Drug Administration at UK, auniversity news release says....
- Kentucky Gets A $7 Million Grant To Improve Survival Rates For Lung Cancer, In Which It Leads The Nation
The University of Kentucky, the University of Louisville and the Lung Cancer Alliance have joined in a unique project called Kentucky LEADS (Lung Cancer, Education, Awareness, Detection, Survivorship) Collaborative to assess new approaches for identifying...
- Uk Creates Nation's First Cancer-reporting System That Uses Electronic Health Records
Kentucky has the highest incidence of cancer in the United States, but it is about to be a national leader in delivering information about cancer cases to researchers. With the help of an almost $1 million Centers for Disease Control grant, the University...
- Markey Cancer Center At Uk Says Its Patients Have Higher Survival Rates Than Those Treated Elsewhere In Ky. And The Nation
"Patients at the University of Kentucky's Markey Cancer Center who have certain types of cancer have higher rates of survival than patients with the same cancers treated elsewhere in the state or even the nation according to new data released today,"...
- Breaking Down The Myths Of Clinical Trials
by Judy Bosley RN, BSN, Oncology Research Nurse Manager The Alvin and Lois Lapidus Cancer Institute Hearing the diagnosis of cancer can be a life changing event. The diagnosis can create many different feelings, anger, disbelief, sadness and shock. Once...